Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Semaglutide GLP-1, initially developed for managing type 2 diabetes, has been FDA-approved since June 2021 for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related condition such as hypertension, type 2 diabetes, or hyperlipidemia
Ahead of any GLP-1 protocol, the Precision Peptide Genetic Test examines 14 pathways, 49 peptides, 150+ genetic insights including the FTO, MC4R, and TCF7L2 markers shaping appetite and energy-balance biology
Clinical studies show semaglutide works best when combined with dietary changes and exercise rather than as a standalone treatment
Compassionate use of remdesivir for patients with severe COVID-19
In retatrutide, GIP activity may work alongside GLP-1 activity to improve metabolic control
If your provider isn't already working with Strive, we're happy to connect and collaborate to ensure your medication regimen includes custom options that meet your needs
US$ 29.91
US$ 25.95
US$ 26.40
